Memoria CD.indd - ISHAM

More documents

Recommendations

Info

• Henrique L. Lenzi. Departamento de Patologia, Fundação Oswaldo Cruz, FioCruz, Rio de Janeiro,RJ, Brazil.• Ildinete Silva Pereira. Departamento de Biologia Celular, Instituto de Ciências Biológicas, Universidadede Brasília, Brasilia, DF, Brazil.• João Santana Silva. Departamento de Bioquimica e da Imunologia, Escola de Medicina, Universidadede São Paulo, Ribeirão Preto, SP, Brazil.• José Daniel Lopes. Disciplina de Imunologia, Departamento de Microbiologia, Imunologia eParasitologia, Centro de Microscopia electrônica, Universidade Federal de São Paulo (UNIFESP),São Paulo, SP, Brazil.• Larissa Fernandes. Departamento de Biologia Celular, Laboratorio de Biologia Molecular, Universidadede Brasilia, Brasilia, DF, Brazil.• Ligia B. Vizeu. Departamento de Geografia, Faculdade de Filosofia, Letras e Ciências Humanas.Universidade de São Paulo, São Paulo, SP, Brazil.• María Adelaide Millington. GT de Pneumonias e Micoses Sistemicas, Ministerio de Saúde,Brasilia, DF, Brazil.• Maria Aparecida Shikanai-Yasuda. Laboratorio de Imunologia, Departamento de Doênças Infecciosase Parasitarias, Faculdade de Medicina, Universidade de São Paulo (FMUSP), São Paulo,SP, Brazil.• Maria Heloisa Blotta. Departamento de Patologia Clínica, Faculdade de Ciências Médicas,Universidade Estatal de Campinas (UNICAMP), Campinas, SP, Brazil.• Maria José Mendes-Giannini. Departamento de Análises Clínicas, Faculdade de CiênciasFarmacêuticas, UNESP, Araraquara, SP Brazil.• Maria Sueli Felipe. Departamento de Biologia Celular, Instituto de Ciências Biologicas, Universidadede Brasilia, Brasilia, DF, Brazil.• Rinaldo Põncio-Mendes. Departamento de Medicina, Faculdade de Medicina, UniversidadeEstatal de São Paulo, Botucatú, SP, Brazil.• Roberto Martinez. Departamento de Molestias Infecciosas da Faculdade de Medicina de RibeirãoPreto, Universidade de São Paulo. Ribeirão Preto, SP, Brazil.• Rosana Puccia. Departamento de Microbiologia, Imunologia e Parasitologia, Divisão de BiologiaCelular, Universidade Federal do São Paulo, São Paulo, SP, Brazil.• Rosely Zancopé Oliveira. Fundação Oswaldo Cruz, Instituto de Pesquisa Clínica Evandro Chagas.Rio de Janeiro, RJ, Brazil.• Vera L. Calich. Departamento da Imunologia, Instituto de Ciências Biomédicas (ICB), Universidadede São Paulo (USP), SP, Brazil.10
Central America• Eduardo Arathoon. Director Médico Clínica Familiar “Luis Angel García”, Asociación de SaludIntegral. Hospital General San Juan de Dios, Guatemala City, Guatemala.• Marion C. de Martin. Departamento de Microbiología, Sección de Micología, Universidad dePanamá, Panamá, Republic of Panamá.Colombia• Ana María García. Corporación para Investigaciones Biológicas (CIB) and Universidad PontificiaBolivariana (UPB), Medellín, Colombia.• Angel González M. Corporación para Investigaciones Biológicas (CIB), and Escuela de Microbiología,Universidad de Antioquia (U de A), Medellín, Colombia.• Angela M. Tobón. Corporación para Investigaciones Biológicas (CIB) and Hospital La María,Medellín, Colombia.• Angela Restrepo M. Corporación para Investigaciones Biológicas (CIB), Medelllín, Colombia.• Manuel Elkin Patarroyo. Instituto de Inmunología, Bogotá, Colombia.• Luz E. Cano. Corporación para Investigaciones Biológicas (CIB) and Escuela de Microbiología,Universidad de Antioquia (UdeA), Medellín, Colombia.Europe• Agostinho João Almeida. Life and Health Sciences Research Institute (ICVS) School of HealthSciences, University of Minho, Campus de Gualtar, Braga, Portugal.• Christopher Kibbler. Department of Medical Microbiology, Royal Free Hospital, London, UnitedKingdom.• Neil AR Gow. School of Medical Sciences, Institute of Medical Sciences. University of Aberdeen,Aberdeen, UK.11
Page 1 and 2: ISSN 0120-4157BiomédicaRevista del
Page 3 and 4: Biomédica Instituto Nacional de Sa
Page 5: Proceedings of theX International C
Page 8 and 9: Financial CommiteeLavive Rebaje de
Page 12 and 13: United States of America• Beatriz
Page 15 and 16: Scholarship WinnersTraveling Award
Page 17 and 18: EditorialIn 1971 the Pan American H
Page 19 and 20: Scientific Program15:00-18:00 Arriv
Page 21 and 22: Symposium 3. Virulence factors and
Page 23 and 24: 16:20-16:4016:40-17:0017:00-17:2017
Page 25 and 26: 14:20-14:4014:40-15:0015:00-15:2015
Page 27 and 28: Symposia IndexPage434344Symposium 1
Page 29 and 30: 91CDC42p controls yeast-cell shape
Page 31 and 32: Poster Index1 Clinical Aspects / Ca
Page 33 and 34: 2-02p 1552-03p 1562-04p 1562-05p 15
Page 35 and 36: 4-20p 1744-21p 1754-22p 1754-23p 17
Page 37 and 38: 5-10p 1915-11p 1925-12p 1925-13p 19
Page 39 and 40: 6-06p 2076-07p 2086-08p 2086-09p 20
Page 41: Symposium1P. brasiliensis:Genomics
Page 44 and 45: Post-genomic contribution to the kn
Page 46 and 47: quence. The first domain (aa 1-1073
Page 49 and 50: Experimental animal models and thei
Page 51 and 52: CD4 + CD25 + FoxP3 + T cells were d
Page 53 and 54: Pattern recognition receptors in th
Page 55: A strategy for the generation of a
Page 59 and 60: Histoplasma virulence mechanisms wi
Page 61 and 62:
Virulence insights from the P. bras
Page 63:
certain antifungal drugs. The effec
Page 67 and 68:
Microbicidal mechanisms exerted by
Page 69 and 70:
depletion induces a more severe and
Page 71 and 72:
did not restore the lymphoprolifera
Page 73 and 74:
Historical accountsCoccidioidomycos
Page 75:
In South America, from Venezuela to
Page 79 and 80:
B-1 cells modulate the kinetics of
Page 81 and 82:
mechanisms can lead to permissivene
Page 83 and 84:
of mice (PBS-untreated as negative
Page 85:
Symposium6Fungal cellular biology A
Page 88 and 89:
wall construction, mating and osmo-
Page 90 and 91:
heat shock proteins, processes of h
Page 92 and 93:
Differential analysis of extracellu
Page 95 and 96:
The evolving public health importan
Page 97:
Several difficulties have been iden
Page 101 and 102:
The impact of histoplasmosis in HIV
Page 103 and 104:
The conjunct data from 66 cases pre
Page 105 and 106:
Although drug serum levels are an o
Page 107 and 108:
Historical accountsHistoplasmosisHi
Page 109:
Histoplasmosis in the United States
Page 113 and 114:
The value and the promise of molecu
Page 115 and 116:
need to consider the P. brasiliensi
Page 117 and 118:
Lymphomononuclear cells of 29 patie
Page 119:
Symposium10Advances on antifungal A
Page 122 and 123:
and Cryptococcus neoformans. MICs f
Page 124 and 125:
sue assay, revelead that P10-PLGA c
Page 127 and 128:
P. brasiliensis growth and infectiv
Page 129 and 130:
Influence of alternating coffee and
Page 131 and 132:
in Arábica and 0.9% Robusta variet
Page 133:
Symposium12Evolutive Biology of P.
Page 136 and 137:
Is Paracoccidioides brasiliensis an
Page 138 and 139:
matter of conjecture. As a global i
Page 141 and 142:
1-01Clinical epidemiology of paraco
Page 143 and 144:
1-05Epidemiological and clinical fe
Page 145 and 146:
1-09Acute severe paracoccidioidomyc
Page 147 and 148:
1-13Nested-PCR, immunoblotting and
Page 149 and 150:
1-17Scintigraphic evaluation of ent
Page 151 and 152:
1-21Paracoccidioidomycosis in a ren
Page 153:
Poster Session2Diagnosis
Page 156 and 157:
2-03Combined use of Paracoccidioide
Page 159:
Poster Session3Epidemiology / Ecolo
Page 162 and 163:
3-03Spatial distribution of chronic
Page 165 and 166:
4-01Towards a molecular genetic sys
Page 167 and 168:
4-05Evidence for positive selection
Page 169 and 170:
4-09Formamidase of Paracoccidioides
Page 171 and 172:
4-13Mating type genes MAT1-1 and MA
Page 173 and 174:
4-17Autophagy in the human pathogen
Page 175 and 176:
4-21Transcription regulation of the
Page 177 and 178:
4-25Changes in the transcription le
Page 179 and 180:
4-29The high affinity copper transp
Page 181 and 182:
4-33Analysis and identification of
Page 183:
4-37The heath shock factor of Parac
Page 187 and 188:
5-01Phenotypic and functional chara
Page 189 and 190:
5-05Polymorphisms analysis of CTLA-
Page 191 and 192:
5-09Alterations in pulmonary mechan
Page 193 and 194:
5-13The influence of ß2 integrin i
Page 195 and 196:
5-17Prostaglandin inhibits Paracocc
Page 197 and 198:
5-21IL-10 deficiency determines a b
Page 199 and 200:
5-25Granulomatous imflammation and
Page 201:
5-29Modulation of experimental para
Page 205 and 206:
6-01Timing of itraconazole therapy
Page 207 and 208:
6-05Amphotericin B-PLGA-DMSA nanopa
Page 209 and 210:
6-09Antagonistic effect of farnesol
Page 211 and 212:
6-13Therapeutic DNA vaccine in BALB
Page 213:
Poster Session7Other Mycoses
Page 216 and 217:
7-03Study of genotypic and phenotyp
Page 218 and 219:
7-07Detection of DNA in peripheral
Page 220 and 221:
Catão E. 193Cavalcante RS. 103, 14
Page 222 and 223:
Molano VM. 143Molina RFS. 199Montoy
Page 224 and 225:
Trinca LA. 167Tristão FSM. 71Urán
Page 226 and 227:
Personal ContributorsDrs. Karl V. a
show all

Memoria CD.indd - ISHAM

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?